1.Association of Lipoprotein Lipase Gene Polymorphism and Coronary Artery Disease in Korean.
Jinsik PARK ; Inho CHAE ; Hyosoo KIM ; Jaeran JU ; Daewon SOHN ; Byunghee OH ; Myungmook LEE ; Youngbae PARK ; Yunsik CHOI ; Youngwoo LEE
Korean Circulation Journal 1999;29(7):663-672
BACKGROUND: The accumulation of lipoprotein and monocyte in the intima of the arterial wall is the most important step of the development of coronary artery disease (CAD). Lipoprotein lipase (LPL) plays an anti-atherogenic role by lipolysis of triglyceride-rich lipoproteins, but, it may also act as a receptor of some lipoproteins and monocyte at the arterial wall and act as a atherogenic molecule. Previous studies showed somewhat contradictory results about the association of CAD and LPL polymorphisms and mutations. Racial and dietary difference may contribute to these contradictory results. In this study, we tried to find out the association of CAD and the genetic variation of the LPL (PvuII RFLP in intron 6, HindIII RFLP in intron 8 and Ser 447 Ter mutation in exon 9) in Korean population. METHOD AND RESULT: CAD patients (n=146), confirmed by coronary angiography and healthy Korean adult volunteers (n=110) were genotyped for PvuII/HindIII RFLP and Ser447Ter mutation of the LPL gene by PCR-digestion method. Between two groups, the genotype frequency of these genetic variations was not different. But, the genetic variations showed different effect on lipid profile and body mass index (BMI) in the CAD group and in the control group. In the CAD group, P1 allele carriers showed higher total cholesterol (P1P1+P1P2:P2P2=216+-51 mg/dl:198+/-38 mg/dl, p=0.039) and higher LDL cholesterol level (P1P1+P1P2:P2P2=143+/-46 mg/dl:126+/-36 mg/dl, p=0.047), and H1 allele carriers had lower Body mass index than non-carriers (23.8+/-2.3 kg/m2 :24.8+/-2.9 kg/m2 , p=0.047). In the control group, the Ser447Ter mutation carriers had higher HDL cholesterol level than non-carriers (59+/-10mg/dl versus 53+/-11mg/dl, p=0.049) and patients with P1 allele showed lower body mass index (P1P1+P1P2: P2P2=23.1+/-2.6 kg/m 2 :24.5+/-2.6 kg/m2 , p=0.006). CONCLUSION: In Korean, PvuII/HindIII RFLP and Ser447Ter mutation was not associated with CAD, and they showed different effect on the lipid profile and on the body mass index according to the study group. These results suggests that the phenotypic characteristics of the LPL gene of the Korean people are different from those of occidental people.
Adult
;
Alleles
;
Body Mass Index
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Coronary Angiography
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Exons
;
Genetic Variation
;
Genotype
;
Humans
;
Introns
;
Lipolysis
;
Lipoprotein Lipase*
;
Lipoproteins*
;
Monocytes
;
Polymorphism, Restriction Fragment Length
;
Volunteers
2.A Small Pancreatic Neuroendocrine Tumor with Marked Pancreatic Duct Dilatation and Parenchymal Atrophy.
Sunghyun WON ; Seung Mo HONG ; Myung Hwan KIM ; Sangwoo PARK ; Yunsik CHOI ; Il Young JANG ; Hyoung Jung KIM
Korean Journal of Medicine 2014;86(5):598-602
Pancreatic ductal adenocarcinomas often cause marked pancreatic duct dilatation and associated parenchymal atrophy. We present the case of a small pancreatic neuroendocrine tumor with upstream pancreatic duct dilatation and severe parenchymal atrophy. A small enhancing tumor was observed at the head of the pancreas on computed tomography (CT). Endoscopic ultrasonography-guided fine-needle aspiration was negative for malignancy. We performed a pylorus-preserving pancreatoduodenectomy since we could not exclude the presence of pancreatic ductal adenocarcinoma. The pathological and immunohistochemical examination revealed a serotonin-positive neuroendocrine tumor, measured 1.0 x 0.5 cm. The pathological specimen was remarkable for the marked stromal fibrosis in the area of the tumor, which resulted in narrowing of the main pancreatic duct. Here, we report a rare small pancreatic neuroendocrine tumor, the CT image of which resembled that of pancreatic ductal adenocarcinoma, in which the expression of serotonin and associated fibrosis might be a possible mechanism for the marked main pancreatic duct dilatation.
Adenocarcinoma
;
Atrophy*
;
Biopsy, Fine-Needle
;
Dilatation*
;
Fibrosis
;
Head
;
Neuroendocrine Tumors*
;
Pancreas
;
Pancreatic Ducts*
;
Pancreaticoduodenectomy
;
Serotonin
3.Eosinophilic organ infiltration without eosinophilia or direct parasite infection.
Il Young JANG ; Young Joo YANG ; Hyung Jin CHO ; Yunsik CHOI ; Eun Hye SHIN ; Dong Uk KANG ; Tae Bum KIM
The Korean Journal of Internal Medicine 2014;29(1):126-129
No abstract available.
Eosinophilia/*diagnosis
;
Female
;
Humans
;
Liver Abscess/*diagnosis/immunology
;
Middle Aged
4.A Case of Cronkhite-Canada Syndrome Showing Spontaneous Remission.
Dong Uk KANG ; Dong Hoon YANG ; Yunsik CHOI ; Ji Beom KIM ; Ho Su LEE ; Hyo Jeong LEE ; Sang Hyoung PARK ; Kee Wook JUNG ; Kyung Jo KIM ; Byong Duk YE ; Jeong Sik BYEON ; Seung Jae MYUNG ; Suk Kyun YANG ; Jin Ho KIM
Intestinal Research 2013;11(4):317-322
Cronkhite-Canada syndrome (CCS) is a rare, noninherited gastrointestinal polyposis syndrome associated with ectodermal changes such as alopecia, nail dystrophy, and cutaneous hyperpigmentation. The etiology and pathogenesis of CCS are not known, but diarrhea, malnutrition, gastrointestinal bleeding, and infection may occur in the affected patient; moreover, this condition could be fatal. However, previous reports have described several cases of spontaneous remission. We report a 60-year-old man who was incidentally found to have colonic polyposis, alopecia, and hypogeusia and was diagnosed to have CCS. However, this patient experienced spontaneous remission, including regrowth of body hair and alleviation of bowel inflammation, without any specific medications such as steroids, antibiotics, or proton pump inhibitors.
Ageusia
;
Alopecia
;
Anti-Bacterial Agents
;
Colon
;
Diarrhea
;
Ectoderm
;
Hair
;
Hemorrhage
;
Humans
;
Hyperpigmentation
;
Inflammation
;
Intestinal Polyposis*
;
Malnutrition
;
Middle Aged
;
Nails
;
Proton Pump Inhibitors
;
Remission, Spontaneous*
;
Steroids
5.Endoscopic and Clinical Factors Affecting the Prognosis of Colorectal Endoscopic Submucosal Dissection-Related Perforation.
Dong Uk KANG ; Yunsik CHOI ; Ho Su LEE ; Hyo Jeong LEE ; Sang Hyoung PARK ; Dong Hoon YANG ; Soon Man YOON ; Kyung Jo KIM ; Byong Duk YE ; Seung Jae MYUNG ; Suk Kyun YANG ; Jin Ho KIM ; Jeong Sik BYEON
Gut and Liver 2016;10(3):420-428
BACKGROUND/AIMS: Although colorectal endoscopic submucosal dissection (ESD)-related perforation is not uncommon, the factors affecting clinical outcomes after perforation have not been investigated. This study was designed to investigate the factors influencing the clinical course of ESD-related colon perforation. METHODS: Forty-three patients with colorectal ESD-related perforation were evaluated. The perforations were classified as endoscopic or radiologic perforations. The patients' medical records and endoscopic pictures were analyzed. RESULTS: The clinical outcomes were assessed by the duration of nil per os, intravenous antibiotics administration, and hospital stays, which were 2.7±1.5, 4.9±2.3, and 5.1±2.3 days, respectively. Multivariate analyses revealed that a larger tumor size, ESD failure, specific endoscopists, and abdominal pain were independently related to a poorer outcome. The time between perforation and clipping was 15.8±25.4 minutes in the endoscopic perforation group. The multivariate analysis of this group indicated that delayed clipping, specific endoscopists, and abdominal pain were independently associated with poorer outcomes. CONCLUSIONS: Tumor size, ESD failure, abdominal pain, and the endoscopist were factors that affected the clinical outcomes of patients with colorectal ESD-related perforation. The time between the perforation and clipping was an additional factor influencing the clinical course of endoscopic perforation. Decreasing this time period may improve outcomes.
Abdominal Pain
;
Anti-Bacterial Agents
;
Colon
;
Humans
;
Length of Stay
;
Medical Records
;
Multivariate Analysis
;
Prognosis*